Publications and Presentations

“Understand Biosimilars and Develop Strategies to Maximize and Defend Your Intellectual Property: Addressing the FDA’s Current Position on Defining Biosimilars,” Thomson Reuters Webinar

August 9, 2012

Email Disclaimer